Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
ARE
|
Lawrence J Diamond
Co-Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct | 2,340 Added 2.43% |
-
|
Mar 31
2022 |
|
ARE
|
Andres Gavinet
Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 302 Reduced 0.5% |
$60,778
$201.25 p/Share
|
Mar 31
2022 |
|
ARE
|
Andres Gavinet
Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct | 2,340 Added 3.71% |
-
|
Mar 31
2022 |
|
ARE
|
Joseph Hakman
Co-Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 463 Reduced 1.21% |
$93,179
$201.25 p/Share
|
Mar 31
2022 |
|
ARE
|
Joseph Hakman
Co-Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct | 1,230 Added 3.13% |
-
|
Mar 31
2022 |
|
ARE
|
Hunter Kass
Co-President and RMD |
BUY
Grant, award, or other acquisition
|
Direct | 7,820 Added 13.89% |
-
|
Mar 31
2022 |
|
ARE
|
Peter M Moglia
Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 4,446 Reduced 2.44% |
$894,758
$201.25 p/Share
|
Mar 31
2022 |
|
ARE
|
Peter M Moglia
Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct | 7,820 Added 4.11% |
-
|
Mar 31
2022 |
|
ARE
|
Terezia C Nemeth
EVP - Regional Market Director |
SELL
Payment of exercise price or tax liability
|
Direct | 305 Reduced 0.93% |
$61,381
$201.25 p/Share
|
Mar 31
2022 |
|
ARE
|
Terezia C Nemeth
EVP - Regional Market Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,230 Added 3.62% |
-
|
Mar 31
2022 |
|
ARE
|
Stephen Richardson
Co-Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 4,605 Reduced 2.48% |
$926,756
$201.25 p/Share
|
Mar 31
2022 |
|
ARE
|
Stephen Richardson
Co-Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct | 7,820 Added 4.04% |
-
|
Mar 31
2022 |
|
ARE
|
Dean A Shigenaga
Former President and CFO |
SELL
Payment of exercise price or tax liability
|
Direct | 3,308 Reduced 2.14% |
$665,735
$201.25 p/Share
|
Mar 31
2022 |
|
ARE
|
Dean A Shigenaga
Former President and CFO |
BUY
Grant, award, or other acquisition
|
Direct | 7,820 Added 4.81% |
-
|
Mar 31
2022 |
|
ARE
|
Madeleine Thorp Alsbrook
EVP - Talent Management |
SELL
Payment of exercise price or tax liability
|
Direct | 305 Reduced 1.67% |
$61,381
$201.25 p/Share
|
Mar 31
2022 |
|
ARE
|
Madeleine Thorp Alsbrook
EVP - Talent Management |
BUY
Grant, award, or other acquisition
|
Direct | 780 Added 4.09% |
-
|
Mar 31
2022 |
|
ARE
|
Kristina Fukuzaki Carlson
EVP - Business Operations |
SELL
Payment of exercise price or tax liability
|
Direct | 466 Reduced 1.74% |
$93,782
$201.25 p/Share
|
Mar 31
2022 |
|
ARE
|
Kristina Fukuzaki Carlson
EVP - Business Operations |
BUY
Grant, award, or other acquisition
|
Direct | 780 Added 2.83% |
-
|
Mar 31
2022 |
|
ARE
|
Orraparn C. Lee
EVP - Accounting |
SELL
Payment of exercise price or tax liability
|
Direct | 305 Reduced 1.05% |
$61,381
$201.25 p/Share
|
Mar 31
2022 |
|
ARE
|
Orraparn C. Lee
EVP - Accounting |
BUY
Grant, award, or other acquisition
|
Direct | 780 Added 2.61% |
-
|
Mar 31
2022 |
|
ARE
|
Steve Hash
Director |
BUY
Grant, award, or other acquisition
|
Direct | 136 Added 0.87% |
-
|
Mar 31
2022 |
|
ARE
|
Michael A Woronoff
Director |
BUY
Grant, award, or other acquisition
|
Direct | 211 Added 2.38% |
-
|
Mar 31
2022 |
|
ARE
|
Daniel J Ryan
Co-President and RMD |
SELL
Payment of exercise price or tax liability
|
Direct | 3,242 Reduced 2.15% |
$652,452
$201.25 p/Share
|
Mar 31
2022 |
|
ARE
|
Daniel J Ryan
Co-President and RMD |
BUY
Grant, award, or other acquisition
|
Direct | 7,820 Added 4.93% |
-
|
Mar 31
2022 |
|
IGMS
|
Redmile Group, LLC
Director |
BUY
Grant, award, or other acquisition
|
Indirect | 230 Added 0.01% |
-
|
Mar 31
2022 |
|
NBIO
|
Sean Carrick
President & CEO |
BUY
Other acquisition or disposition
|
Direct | 430,000 Added 2.4% |
$25,800
$0.06 p/Share
|
Mar 31
2022 |
|
NBIO
|
Lowell Thomas Holden
CFO |
BUY
Other acquisition or disposition
|
Direct | 215,000 Added 2.34% |
$12,900
$0.06 p/Share
|
Mar 31
2022 |
|
REPH
|
Ryan David Lake
Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 1,198 Reduced 0.23% |
$2,156
$1.8 p/Share
|
Mar 31
2022 |
|
BICX
|
Luisa Ingargiola |
BUY
Grant, award, or other acquisition
|
Direct | 1,408 Added 5.29% |
-
|
Mar 31
2022 |
|
BICX
|
Kent Emry |
BUY
Grant, award, or other acquisition
|
Direct | 1,408 Added 1.45% |
-
|
Mar 31
2022 |
|
LIND
|
David Goodman
Chief Commercial and Marketing |
BUY
Grant, award, or other acquisition
|
Direct | 28,184 Added 15.21% |
-
|
Mar 31
2022 |
|
LIND
|
David Goodman
Chief Commercial and Marketing |
SELL
Payment of exercise price or tax liability
|
Direct | 1,496 Reduced 0.95% |
-
|
Mar 31
2022 |
|
PCSA
|
Robert Michael Floyd
Chief Operating Officer |
SELL
Bona fide gift
|
Direct | 7,000 Reduced 8.98% |
-
|
Mar 31
2022 |
|
BFST
|
Philip Jordan
EVP&CBO of b1Bank |
SELL
Payment of exercise price or tax liability
|
Direct | 2,614 Reduced 5.12% |
$63,599
$24.33 p/Share
|
Mar 31
2022 |
|
SLNO
|
Jack W Schuler |
BUY
Open market or private purchase
|
Indirect | 4,000,000 Added 33.58% |
-
|
Mar 31
2022 |
|
BAND
|
John C. Murdock
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 596 Added 0.76% |
-
|
Mar 31
2022 |
|
TVTY
|
Anthony Michael Sanfilippo
Director |
BUY
Grant, award, or other acquisition
|
Indirect | 1,166 Added 6.04% |
-
|
Mar 31
2022 |
|
TVTY
|
Erin L Russell
Director |
BUY
Grant, award, or other acquisition
|
Direct | 612 Added 1.92% |
-
|
Mar 31
2022 |
|
TVTY
|
Sara Finley
Director |
BUY
Grant, award, or other acquisition
|
Direct | 661 Added 1.67% |
-
|
Mar 31
2022 |
|
TVTY
|
Stephanie M. Davis
Director |
BUY
Grant, award, or other acquisition
|
Direct | 423 Added 16.48% |
-
|
Mar 31
2022 |
|
MDV
|
Connie Tirondola
Director |
BUY
Grant, award, or other acquisition
|
Direct | 696 Added 44.99% |
$12,486
$17.94 p/Share
|
Mar 31
2022 |
|
MDV
|
Adam Scott Markman
Director |
BUY
Grant, award, or other acquisition
|
Direct | 836 Added 7.43% |
$14,998
$17.94 p/Share
|
Mar 31
2022 |
|
MDV
|
Curtis B Mc Williams
Director |
BUY
Grant, award, or other acquisition
|
Direct | 836 Added 7.21% |
$14,998
$17.94 p/Share
|
Mar 31
2022 |
|
MDV
|
Aaron Scott Halfacre
CEO and President |
BUY
Open market or private purchase
|
Direct | 3,000 Added 13.18% |
$54,390
$18.13 p/Share
|
Mar 31
2022 |
|
MDV
|
Asma Ishaq |
BUY
Grant, award, or other acquisition
|
Direct | 696 Added 44.99% |
$12,486
$17.94 p/Share
|
Mar 31
2022 |
|
MDV
|
Kimberly J Smith
Director |
BUY
Grant, award, or other acquisition
|
Direct | 696 Added 44.99% |
$12,486
$17.94 p/Share
|
Mar 31
2022 |
|
MDV
|
Thomas H Nolan Jr
Director |
BUY
Grant, award, or other acquisition
|
Direct | 836 Added 7.61% |
$14,998
$17.94 p/Share
|
Mar 31
2022 |
|
ZSANQ
|
Steven Lo
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 23,633 Reduced 4.88% |
$4,963
$0.21 p/Share
|
Mar 31
2022 |
|
ZSANQ
|
Donald J Kellerman
VP, Clinical Dev & Med Affairs |
SELL
Open market or private sale
|
Direct | 4,006 Reduced 6.64% |
$841
$0.21 p/Share
|
Mar 31
2022 |
|
ZSANQ
|
Christine Matthews
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 8,116 Reduced 5.25% |
$1,704
$0.21 p/Share
|
Mar 31
2022 |